Cannabis Industry Solutions
Gain a competitive edge in the cannabis industry by leveraging MSA’s data analytics expertise to understand your customers. Partner with us to gain valuable insights into the performance of cannabis products across demographics and other industries, empowering you to make informed decisions and stay ahead of the market.
Get Real-World Data
Data For Cannabis Operators
Gain market insights to real-world, quantitative data among your consumer demographics.
Data For Research Entities and Healthcare Professionals
Partner in cannabis research initiatives across the country and access valuable data from the state-legal cannabis industry integrated with real-world healthcare data.
MSA Partners with Cannabis Operators
MSA partners with cannabis operators across the US to analyze Point-of-Sales data on a demographical level through their HIPAA compliant, de-identification software. By providing real-world data, operators understand their customers and reveal valuable company insights; preferred product forms, favored brands, retention rates and more.
Why is Cannabis Research Needed?
Learn why MSA is dedicated to advancing scientific research here.
MSA and BDSA Partnership
BDSA is the leading provider of data and insights for the cannabis industry through providing retailers, manufacturers, brands, wholesalers, and investors with actionable insights to drive profitability, increase revenues, eliminate expenses, and outmaneuver the competition. Through MSA’s capability to analyze cannabis operators’ real-world data in coordination with BDSA’s extensive insights into the cannabis industry, we offer one-of-kind advisory to help understand your consumers, influence business and sales strategies, and more.
To schedule a consultation with MSA and BDSA please click here.
Supporting Partners and Affiliations
Steve Gongaware, MSA’s EVP of Business Development, sits on NCIA’s Scientific Advisory Committee (SAC). The SAC is comprised of practicing chemists and other scientific field professionals to advise other NCIA committees as they work to develop standards and guidelines for the various sectors of our industry, ensuring that any formal recommendations produced by other NCIA committees are scientifically sound, sustainable, and legitimate.
Tetragram allows cannabis consumers to document their health goals, decode their usage, and discover their communities. Finding the best cannabis products through trial and error is overwhelming, expensive, and time-consuming. With Tetragram’s App cannabis consumers can find relief and discover the optimal cannabis experience.
The Midwest CannaNurses connect cannabis and healthcare by offering educational resources, encouraging informed consumption and developing individualized care plans for holistic treatment. They advocate for safe, effective cannabis use by demanding destigmatization and decriminalization for communities of color. As partners, we work to further cannabis research in Michigan.
In the News
A series of studies and reports highlight the potential benefits of medical cannabis in reducing opioid use among chronic pain patients. These findings suggest that cannabis may serve as an effective alternative for pain management, offering a safer option with fewer risks of addiction and overdose compared to opioids. MSA is actively exploring how cannabis can address broader health and wellness needs, using real-world data to conduct comprehensive studies. These efforts contribute to the growing body of evidence supporting the integration of medical cannabis into healthcare strategies to combat the opioid crisis and improve patient outcomes. If you’re interested in learning more or have questions, please reach out to Madeline Grant at mgrant@msa.com.
- Legalizing Medical Marijuana In Utah Helped Reduce Opioid Use By Pain Patients, Study Finds Read here…
- New Study Finds Medical Cannabis In Utah Helped Reduce Opioid Use A Possible Nationwide Trend Read here…
- Cannabis Cuts Opioid Prescriptions By 53%, Utah Study Suggests Read here…
- Cannabis Impact On Opioid Prescriptions In Utah Read here…
- Cannabis Could Help Reduce Opioid Use in Patients with Chronic Pain Read here…
PODCAST: One Mic Stand: DEEP DIVE with Management Science Associates
Interview by Audrey Russo and Jonathan Kersting | December 15, 2023
Listen to the story of MSA’s growth and how it is looking to be a leader in the emerging cannabis industry. Listen here…
Member Blog: Management Science Associates, Inc. Leads Research Initiatives Alongside Vireo Health
The article highlights Management Science Associates, Inc. (MSA) and Vireo Health’s collaborative research efforts within the cannabis industry. Together, they aim to address research gaps and enhance understanding through data-driven approaches. Read here…
Breaking New Ground: BDSA and MSA Forge Strategic Alliance to Deliver Next-Level Cannabis Industry Market Research and Analytics
June 22, 2023 09:00 ET | Source: BDSA
Data powerhouses work together to redefine understanding of cannabis consumers and markets. Read here…
MSA offers insight into medical cannabis industry
By Paul J. Gough – Reporter, Pittsburgh Business Times – Mar 17, 2023
The article provides insights from Management Science Associates (MSA) into the medical cannabis industry. MSA, a data analytics firm, sheds light on various aspects of the industry, including market trends, consumer behavior, and regulatory developments. Through their analysis, MSA offers valuable information for businesses and stakeholders navigating the evolving landscape of medical cannabis. Read here…
Upcoming Events/Past Events
UPCOMING EVENTS
MJBizCon | December 3-6, 2024, Las Vegas, Nevada
MJBizCon has over 30,000 cannabis executives and entrepreneurs from around the world, you’ll be in great company as you connect with the best and brightest in the industry.
PAST EVENTS
MJ Unpacked | November 5-7, 2024, St. Louis, Missouri
Madeline Grant, is presenting “Exploring Cannabis as a Substitute to Prescription Opioids Through Data” at MJ Unpacked, a distinctive event for nationwide license holders and accredited investors to connect, collaborate, and prepare for expansion.
Benzinga Cannabis Capital Conference | October 8-9, 2024, Chicago, Illinois
The Leading Cannabis Investment & Branding Conference In North America.
10th Annual CWCBExpo | June 5-6, 2024, New York, New York
CWCBExpo is the premier cannabis business-to-business expo and conference on the East Coast. Learn more…
The Cannabis Alliance 9th Annual Washington Cannabis Summit | May 10, 2024, Seattle, Washington
Madeline Grant, Manager at MSA, is speaking on “The Ins and Outs of (De/Re) Scheduling Cannabis” panel. Learn more…
CannMed 24 Innovation and Investment Summit | May 12-15, 2024, Marco Island, Florida
Stephen Gongaware, MSA’s EVP of Business Development, is presenting a poster at CannMed 2024. To learn more Click here. Since 2016, CannMed has regularly featured some of the greatest minds in medicinal plant medicine, cultivation, and safety testing. It is the most sought after forum in which to announce the latest research and technologies, while networking with current and prospective customers. Learn more…
NCIA’s 12th Annual Cannabis Industry Lobby Days | May 14-16, 2024, Washington, D.C.
This is your opportunity to stand alongside fellow industry leaders and passionately advocate for the critical issues impacting small cannabis businesses. Connect with national lawmakers to share your personal stories that resonate with the needs of Main Street Cannabis businesses while making meaningful connections with industry colleagues and advocates from across the nation. Learn more…
Benzinga Cannabis Capital Conference | April 16-17th, 2024, Hollywood, FL.
The Leading Cannabis Investment & Branding Conference In North America. Learn more…
MJ Unpacked | April 9-11, 2024 Atlantic City, New Jersey
Stephen Gongaware, EVP at MSA, is presenting “Exploring Cannabis as a Substitute to Prescription Opioids Through Data” at MJ Unpacked, a distinctive event for nationwide license holders and accredited investors to connect, collaborate, and prepare for expansion. Learn more…
THE EMERALD CONFERENCE | March 2023, San Diego, CA.
Stephen Gongaware, MSA’s EVP of Business Development, was a poster presenter at The Emerald Conference, which is the original, longest running interdisciplinary cannabis science and psychedelics science event. It is the forum for highlighting the latest research, scientific advancements, and practical applications fostering innovation in cannabis cultivation, processing and product development. View presentation here…